Badrilla Ltd is a UK based biotechnology company founded in 2003 that makes exceptional antibodies to cardiovascular protein and phospho-protein targets. Working with outstanding academic collaborators, we are developing new calibration technologies, which will enable the performance of genuinely quantitative western blotting. Badrilla Ltd has always strived to make positive contributions to the antibody market via thorough product validation and honest data presentation.
Tuesday, 28 August 2018
BADRILLA ATTENDS 23RD NCRG MEETING IN NEWCASTLE
We were very pleased to be able to attend the 23rd Northern Cardiovascular Research Group meeting in Newcastle upon Tyne on the 21st April 2015. The meeting provided an excellent range of speakers and posters and there were some good opportunities for networking with existing and future collaborators alike.
Business Development Manager Ben Voysey commented: "We very much favour the smaller, more focussed scientific meetings as they allow us to keep up-to-date and closely aligned with key developments in the cardiovascular field. The NCRG meeting provides an excellent platform for this and we are always pleased to be involved with events of this type".
We were also delighted to be trying out our newly branded exhibition scheme and offering lots of free Badrilla goodies, including ballpoint pens, lab markers and our very popular Badrilla mugs. Thank you to everyone for all of your positive feedback on our new logo and branding and we look forward to seeing you at the next cardiovascular research-themed meeting.